These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 11864851)
1. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Goldstone AP; Brynes AE; Thomas EL; Bell JD; Frost G; Holland A; Ghatei MA; Bloom SR Am J Clin Nutr; 2002 Mar; 75(3):468-75. PubMed ID: 11864851 [TBL] [Abstract][Full Text] [Related]
2. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Lloret-Linares C; Faucher P; Coupaye M; Alili R; Green A; Basdevant A; Clément K; Poitou C Int J Obes (Lond); 2013 Sep; 37(9):1198-203. PubMed ID: 23318724 [TBL] [Abstract][Full Text] [Related]
4. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. Orsso CE; Mackenzie M; Alberga AS; Sharma AM; Richer L; Rubin DA; Prado CM; Haqq AM Metabolism; 2017 Apr; 69():67-75. PubMed ID: 28285653 [TBL] [Abstract][Full Text] [Related]
5. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement. Myers SE; Davis A; Whitman BY; Santiago JV; Landt M Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760 [TBL] [Abstract][Full Text] [Related]
6. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome. Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398 [No Abstract] [Full Text] [Related]
7. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Talebizadeh Z; Butler MG Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361 [TBL] [Abstract][Full Text] [Related]
8. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. van Mil EA; Westerterp KR; Gerver WJ; Curfs LM; Schrander-Stumpel CT; Kester AD; Saris WH Am J Clin Nutr; 2000 Mar; 71(3):752-6. PubMed ID: 10702169 [TBL] [Abstract][Full Text] [Related]
9. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Höybye C Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552 [TBL] [Abstract][Full Text] [Related]
10. Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes. Proto C; Romualdi D; Cento RM; Romano C; Campagna G; Lanzone A Metabolism; 2007 Aug; 56(8):1076-80. PubMed ID: 17618952 [TBL] [Abstract][Full Text] [Related]
11. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. Bekx MT; Carrel AL; Shriver TC; Li Z; Allen DB J Pediatr; 2003 Sep; 143(3):372-6. PubMed ID: 14517523 [TBL] [Abstract][Full Text] [Related]
12. Activity related energy expenditure in children and adolescents with Prader-Willi syndrome. van Mil EG; Westerterp KR; Kester AD; Curfs LM; Gerver WJ; Schrander-Stumpel CT; Saris WH Int J Obes Relat Metab Disord; 2000 Apr; 24(4):429-34. PubMed ID: 10805499 [TBL] [Abstract][Full Text] [Related]
13. Energy expenditure and body composition in Prader-Willi syndrome. Schoeller DA; Levitsky LL; Bandini LG; Dietz WW; Walczak A Metabolism; 1988 Feb; 37(2):115-20. PubMed ID: 3340003 [TBL] [Abstract][Full Text] [Related]
14. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome. Hirsch HJ; Gross I; Pollak Y; Eldar-Geva T; Gross-Tsur V PLoS One; 2015; 10(9):e0136864. PubMed ID: 26334732 [TBL] [Abstract][Full Text] [Related]
15. Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity? Bedogni G; Grugni G; Tringali G; Marazzi N; Sartorio A J Endocrinol Invest; 2015 Sep; 38(9):957-61. PubMed ID: 25840793 [TBL] [Abstract][Full Text] [Related]
16. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464 [TBL] [Abstract][Full Text] [Related]
17. Does circulating leptin play a role in energy expenditure? Bi X; Loo YT; Henry CJ Nutrition; 2019 Apr; 60():6-10. PubMed ID: 30508765 [TBL] [Abstract][Full Text] [Related]
18. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. Myers SE; Carrel AL; Whitman BY; Allen DB J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820 [TBL] [Abstract][Full Text] [Related]
19. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome. Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437 [TBL] [Abstract][Full Text] [Related]